A����� �� � ������� ����������� ������� ���������-ized by the inflammation of the airways due to infiltration and activation of several inflammatory cells that produce cytok����. �-kit, � �����-����g��� ���� ������� � �������� k����� receptor, has been found to be associated with allergic inflammation. The aim of the present study was to assess whether silencing of c-kit with small interference RNA (siRNA) would attenuate inflammation in allergic asthma. A mouse model of ovalbumin (OVA)-induced allergic asthma was treated with systemic administration of anti-c-kit siRNA to inhibit the expression of the c-kit gene. siRNAs were injected through the vena caudalis. We measured inflammatory response in both anti-c-kit siRNA-treated and control mice. Systemic administration of siRNA could effectively inhibit the expression of the c-kit gene and reduce the infiltration of inflammatory cells (eosinophils and lymphocytes) into the lung tissue and bronchoalveolar lavage fluid. In addition, we found that c-kit siRNA can decrease the production of the T-helper type 2 (Th2) cytokines, interleukin � (I�-�) and I�-�, but has no infl uinterleukin � (I�-�) and I�-�, but has no infl u-(I�-�) and I�-�, but has no influ-���� �� IFN-γ generation. These results show that inhibition of c-kit expression with siRNA can reduce the inflammatory response in allergic asthma.
Introduction
A����� �� � ������� ����������� ������� ����������z�� b� inflammation of the airways due to infiltration and activation of several inflammatory cells (mast cells, eosinophils, and T lymphocytes), which produce cytokines and proinflammatory molecules such as leukotrienes, interleukins, and chemotactic factors (1, 2) . Antigen-presenting cells (APCs), especially dendritic cells, initiate and regulate the allergic responses of T-helper type 2 (Th2) cells to allergens in asthma. APCs present allergens that are taken up and processed by Th2 cells, which leads to Th2 cell activation. Activated Th2 cells produce a series of cytokines, such as interleukin � (I�-�), I�-� and I�-13, which play a prominent role in disease pathogenesis by inducing the survival and recruitment of eosinophils and mast cells, by inducing goblet cell hyperplasia and bronchial hyperreactivity (3) .
RNA interference (RNAi) is an innate mechanism in most eukaryotes, in which double-stranded RNA inside the cell targets the degradation of cognate mRNA in a sequencespecific manner (�) . In recent years, in vivo small interference RNA (siRNA) delivery has been used to study specific gene functions and satisfactory results have been achieved (�) .
T�� �����-����g��� �-kit �� � ���b���� �������� k����� receptor encoded at the white spotting locus (W) and its ligand is stem cell factor (SCF). c-kit is critical for the proliferation, survival and differentiation of hematopoietic stem and progenitor cells and several non-hematopoietic tissues (6) . A recent study showed that the inflammation in allergic asthma is alleviated in c-kit-defective mice, which indicates that c-kit plays a role in the development of allergic inflammation (7) .
However, whether RNAi can attenuate the inflammation of allergic asthma mediated by c-kit is unknown. In this study, we used specific siRNA to silence the expression of the c-kit gene and investigated the effect of c-kit on allergic airway inflammation in an experimental model of asthma. We found that siRNA could inhibit the development and promote the resolution of airway inflammation.
Materials and methods
Experimental asthma model. Six to eight-week-old SPF-grade male C�7B�/6 mice (20-2� g) were purchased from the �aboratory Animal Center of West China Hospital, Sichuan University. Experimental protocols were approved by the Institutional Animals Ethics Committee of West China School of Medicine, Sichuan University.
The experimental model of asthma was generated as previously described (8) . Briefly, mice were sensitized by administering ovalbumin (OVA, 20 µg, grade V; SigmaAldrich) with aluminum hydroxide (alum, 2.2� mg; Imject Alum; Pierce Biotechnology, Inc.) in a 100 µl total volume via intraperitoneal (i.p.) injection on Days 0 and 7. Mice were challenged with � doses of aerosolized 1% OVA, each for 30 min, on Days 1�-18. Mice were sacrificed with a lethal dose of pentobarbital via i.p. injection on Day 21.
Screening and chemical modification of the siRNA sequence.
The siRNA sequence used for targeted silencing of c-kit [GenBank accession no. NM_021011] was designed by Qiagen, and siRNA sequences were selected according to the method of Sikarwar and Reddy (9) . In addition, target siRNA was chemically modified by methylation to avoid or lessen its destruction in the blood (10) . We selected two c-kit-specific siRNA duplexes on the basis of a previous in vitro study and used them as a mixture consisting of an equal amount of each siRNA duplex (9) . We also designed a pair of control siRNAs, namely, scrambled siRNA and the sequence of scrambled siRNA with no complementation with any other genes in mice, which aims to avoid specific gene silencing. All the siRNAs were synthesized by Qiagen. Briefly, for each oligonucleotide, the 2 individual complementary strands of the siRNA were synthesized separately by the solid-phase method and then purified separately by ion-exchange chromatography. The complementary strands were annealed to form the doublestranded siRNA (duplex). The duplex was then ultrafiltered and lyophilized to form the solid drug substance (Table I) .
siRNA knockdown of mouse c-kit in vivo. Mice were placed in a metal restrainer. Their tails were warmed by immersing in warm water (��˚C, 1 min) to dilate the blood vessels and were swabbed with alcohol. With the tail stretched, a hypodermic needle (30G) was inserted approximately parallel to the lateral tail vein. Appropriate needle placement was ensured by inserting the needle at least 3 mm into the vein lumen. The intravenous (i.v.) administration of siRNA was performed with caution to avoid rupture of the blood vessels during injection. The mice were divided into 3 groups of � mice each. The first group of asthmatic mice was injected with 0.1 ml of PBS vehicle. The second and third groups of mice were injected with �, 10 or 20 µg of specific siRNA for murine c-kit ��� scrambled siRNA for 3 consecutive days from Days 16 to 18, respectively. The lung tissue and bronchoalveolar lavage fluid (BA�F) were collected 72 h after the last injection.
Counting of inflammatory cells in the BALF. Bronchoalveolar lavage (BA�) with 1 ml of HBSS, instilled bilaterally with a syringe, provided lavage fluid, which was harvested by gentle aspiration 3 times and then centrifuged (11) . The cells in the BA�F were resuspended in PBS and counted with a hemocytometer. The cells were cytocentrifuged using Cytospin and then stained with Wright-Giemsa stain (Sigma) for counting of inflammatory cell subsets (eosinophils, alveolar macrophages and lymphocytes); 200 or more cells per slide were counted.
Enzyme-linked immunosorbent assay. The levels of inflammatory cytokines in the BA�F were analyzed by enzyme-linked immunosorbent assays (E�ISA), using E�ISA kits for I�-�, I�-�, IFN-γ and I�-6 (R&D Systems, Inc., USA) according to the manufacturer's instructions. Five mice were used for each group per experiment.
Histology. �ung tissue blocks from the right upper and right middle lobes were rinsed in normal saline and fixed in 10% formalin for 2� h. The specimens were then embedded in paraffin after being dehydrated through ascending grades of ethanol and cleared in toluene. The tissue blocks were sectioned at � µm with a �eica rotary microtome. Paraffin sections were mounted on albuminized glass slides by floating and flattening the sections in a water bath at ��˚C. The mounted sections were drained until dry and kept in an incubator at 30˚C. Paraffin sections were first dewaxed in 2 changes of xylene, then passed through descending grades of alcohol, and finally washed in deionized water before staining with hematoxylin and eosin for 1 min at room temperature. The sections were rinsed 3 times in deionized water, then quickly dehydrated through ascending grades of ethanol, and passed through xylene before being mounted with Permount; the sections were then photographed and evaluated. The paraffin sections were stained with hematoxylin and eosin and periodic acid-Schiff reagent (Sigma).
RT-PCR for c-kit. For RNA isolation, the whole left lungs were frozen in liquid nitrogen, stored at -80˚C and frozen immediately after removal from mice in each group. Total-RNA was extracted from frozen lung tissue using TRIzol reagent (Gibco-BR�, Gaithersburg, MD) and amplified using the Promega PCR single-step kit (Promega, Madison, WI), ��������g �� ��� manufacturer's instructions. Total-RNA was transcribed into cDNA with reverse transcriptase kit at �0˚C for 30 min. The following primers for murine c-kit were used: forward, �'-ACCCACAGGTGTCCAATTATTC-3' and reverse, �'-TGG CGTTCATAATTGAAGTCAC-3' . β-����� ���v�� �� ��� internal control. The PCR products were electrophoresed on a 3% agarose gel and visualized by ethidium bromide staining. Table I . Characteristics of c-kit and scrambled siRNA.
Target
Accession no.
Western blotting. Tissue blocks from the left lobe of the lung were immediately immersed in liquid nitrogen. The tissues were ground and then lysed in RIPA lysis buffer. �ysate (�0 µg) was loaded per well and resolved on a 10% polyacrylamide gel (SDS-PAGE) under denaturing conditions; the proteins were transferred onto 0.�� µm nitrocellulose membranes. The blots were probed for murine c-kit using a murine c-kit antibody (Santa Cruz Biotechnology, Inc.); they were also probed with the GAPDH antibody as a loading control (Santa Cruz Biotechnology, Inc.). Bands were visualized using an antirabbit IgG-HRP-conjugated secondary antibody and the EC� western blotting detection system (GE Healthcare, UK).
Statistical analysis.
The results are expressed as the mean ± SD, unless indicated otherwise. Statistical analysis was performed by the SPSS software using one-way analysis of variance (ANOVA), followed by �SD significant difference test. A value of P<0.0� (two-tailed test) was considered statistically significant.
Results

siRNA attenuates the inflammatory response in the BALF.
All BA�F samples were obtained 3 days after the injection of siRNA or PBS vehicle on Day 21. The number of total cells, eosinophils and lymphocytes in BA�F decreased more significantly in the c-kit siRNA group than in the control and scrambled-siRNA groups (P<0.0�) (Fig. 1b, c and e) . The number of macrophages in the c-kit-siRNA group was lower than those in the control or the scrambled-siRNA group, but the difference was not significant (P>0.0�) (Fig. 1d) .
c-kit siRNA selectively regulates the production of cytokines in the BALF. The production of the Th2 cytokines I�-� and I�-� decreased to a greater extent in the c-kit siRNA group than in the control and scrambled-siRNA groups ( Fig. 2a and b) ; the same pattern was observed in the production of I�-6 (Fig. 2c) . The production of IFN-γ, a Th1 cytokine, did not increase with the decrease in Th2 cytokines (Fig. 2d) .
siRNA attenuates the inflammatory response of lung tissue and reduces the secretion of mucus in the airways of asthmatic mice. Histological examination of lung specimens revealed that c-kit siRNA attenuated the inflammatory response to a greater extent in the lung tissue than in the control and scrambledsiRNA groups. Compared with the control group, the number of inflammation cells that infiltrated in lung tissue was lower in the c-kit siRNA group (Fig. 3) .
c-kit siRNA can downregulate the expression of c-kit gene in lung tissue.
To investigate whether c-kit-specific siRNA could silence the expression of the c-kit gene, we detected levels of the c-kit mRNA by reverse transcription-polymerase chain reaction (RT-PCR). In comparison with the control group and scrambled siRNA group, the result showed that the mRNA expression of c-kit mRNA was downregulated in the anti-ckit siRNA group at 72 h after the last administration, which indicated that anti-c-kit siRNA can effectively inhibit the expression of the c-kit gene (Fig. �) .
Western blot analysis indicates that c-kit siRNA inhibits the expression of c-kit protein.
Western blot analysis showed that anti-c-kit siRNA could effectively inhibit the expression of c-kit protein at 72 h post-transfection in the c-kit siRNA group; in contrast, the control and scrambled-siRNA groups showed expression of c-kit protein in lung tissue (Fig. �) .
Discussion
In the majority of eukaryotes, RNAi is an evolutionarily conserved process that inhibits gene expression primarily by targeting mRNAs (12) . To date, numerous studies have been conducted in a variety of animal models to investigate the efficacy of siRNAs as therapeutic agents; their findings indicate that specific siRNAs could inhibit the expression of target genes when administered locally or systemically (13,1�) . In this study, we used a mouse model of allergic asthma; the mice were systematically administered c-kit siRNA by i.v. injection. We obtained evidence that c-kit siRNA acts as an anti-inflammatory and pro-resolution mediator of allergic airway inflammation. T�� �-kit proto-oncogene has been found to be expressed in a wide range of non-hematopoietic cell types (with the exception of hematopoietic stem and/or progenitor mast cells), including vascular endothelial cells and interstitial cells of Cajal, which control gut motility, astrocytes, renal tubules, breast glandular epithelial cells and sweat glands (1�-19) . A few studies have shown high cell-surface expression of c-kit �� the human airway epithelia of asthmatic patients (20, 21) .
c-kit is a member of the PDGF family of receptor tyrosine kinases and is the ligand of the stem cell factor (SCF). The c-kit receptor is present in mast cells, eosinophils and lymphocytes (22) . These cells play an important role in the development of asthmatic airway inflammation (23) . In our study, we used specific siRNA to inhibit the expression of c-kit and found that it could attenuate inflammation in allergic asthma. The number of total cells, eosinophils and lymphocytes markedly decreased in the BA�F from the mice administered c-kit siRNA. Histopathologic examination of the lung showed that treatment with c-kit siRNA reduced the inflammation of lung tissue in the airways. The c-kit ligand or SCF has been identified as a primary inducer of mast cell differentiation, proliferation and activation. Blocking c-kit/c-kit ligand interaction could significantly decrease eosinophils in BA�F (2�) . Some studies have shown that c-kit/SCF enhances IgE-dependent mediator release from mast cells, such as histamine and leukotrienes (2�,2�). c-kit/SCF is closely related to airway infiltration of mast cells and eosinophils which promotes degranulation of mastocytes. Our study showed that anti-c-kit siRNA could effectively downregulated c-kit expression, which contribute to reducing allergic inflammation mediated by c-kit in mice.
Four isoforms of c-kit in humans have been identified, which result from alternate mRNA splicing. Each isoform differs in signaling and function (26) . Previous studies have shown that the function of c-kit is induced by the activation of several different signaling pathways, including MAPK, PI-3 kinase and the small GTPase Rac, which are independent pathways that interact in signal transduction (6) . The c-kit-PI3 kinase signaling axis positively regulates the production of I�-6; moreover, c-kit is associated with Th2 responses through the Notch ligand Jagged-2 signaling pathway (7, 27) . I�-6 has been associated with Th2 and Th17 differentiation (28) . In our study, the production of I�-6 in the BA�F decreased to a markedly greater extent in the c-kit siRNA group than in the control group, which suggests that PI-3 kinase plays a role in regulating I�-6 production. Therefore, we hypothesized that the Notch signaling pathway is involved in the production of Th2 cytokines (I�-� and I�-�) through Th2 cell polarization mediated by c-kit. Furthermore, c-kit upregulation on dendritic cells led to immune skewing toward T helper Th2 and Th17 subsets and away from Th1 responses (29) . Silencing of the c-kit gene with specific siRNA suppressed the production of I�-6 and Th2 and Th17 responses, which attenuated the allergic inflammation mediated by c-kit. On the other hand, inhibition of Th2 response results in the decrease of I�-� and I�-� production.
I�-� and I�-�, which are Th2 cytokines, play an important role in the development of allergic asthma. Previous studies using a murine model of asthma have shown that treatment with antisense phosphorothioate oligonucleotides to the c-kit ligand suppresses airway inflammation, I�-� production and eosinophilia (30) . In addition, I�-� promotes IgE synthesis, contributes to early recruitment of eosinophils and is detected as early as 3 h after challenge (31) (32) (33) . Additionally, I�-� production leads to production of I�-� and other cytokines in asthma (3�) . I�-� is the most important chemokine in the recruitment of eosinophils into the airway. In our study, we found that the levels of I�-�, I�-� and I�-6 decreased in the BA�F from the mice treated with c-kit siRNA, which suggests that activation of c-kit could promote the production of I�-�, and that I�-� plays a pivotal role in asthma pathogenesis. Thus, c-kit siRNA inhibits c-kit activation, which results in a decrease in I�-� production and, consequently, a lower production of I�-�; this leads to diminished recruitment of eosinophils into the airway and, ultimately, to a decrease in the number of eosinophils in the BA�F. In addition, we found that the number of lymphocytes decreased in the BA�F from the group treated with c-kit siRNA; however, the mechanism of this effect is unclear.
In conclusion, our data show that c-kit-specific siRNA attenuates inflammation in a mouse model of OVA-induced allergic asthma through inhibiting the production of inflammatory cytokines. We have shown that systemically administered siRNA can induce target gene silencing, which indicates the potential use of c-kit siRNA in the treatment of asthma.
